Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
Want to see IONS full AI Analyst Report?
Ionis Pharmaceuticals (IONS) Ownership Overview
0.74% Insiders
41.99% Mutual Funds
4.51% Other Institutional Investors
15.25% ETFs
37.52% Public Companies and
Individual Investors
The ownership structure of Ionis Pharmaceuticals (IONS) stock is a mix of institutional, retail, and individual investors. Approximately 61.75% of the company’s stock is owned by Institutional Investors, 0.74% is owned by Insiders, and 37.52% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 04, 2026 | xxxxxxxxxxxxx | $7055489 | |
Feb 02, 2026 | xxxxxxxxxxxxx | $512424 | |
Feb 02, 2026 | xxxxxxxxxxxxx | $581681 | |
Feb 02, 2026 | xxxxxxxxxxxxx | $488102 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $195000612 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $600920 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $33460998 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $141752542 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,296,859 | Institution | 8.05% | 1,010,827,221 | |
| 12,621,246 | Institution | 7.64% | 959,467,121 | |
| 12,523,415 | Institution | 7.58% | 952,030,008 | |
| 7,668,655 | Institution | 4.64% | 582,971,153 | |
| 4,802,251 | Institution | 2.91% | 365,067,121 | |
| 4,723,802 | Institution | 2.86% | 359,103,428 | |
| 4,219,888 | Institution | 2.55% | 320,795,886 | |
| 3,982,987 | Institution | 2.41% | 302,786,672 | |
| 3,803,181 | Institution | 2.30% | 289,117,820 | |
| 2,867,226 | Institution | 1.73% | 217,966,521 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,621,246 | Institution | 7.64% | 959,467,121 | |
| 12,523,415 | Institution | 7.58% | 952,030,008 | |
| 7,668,655 | Institution | 4.64% | 582,971,153 | |
| 4,723,802 | Institution | 2.86% | 359,103,428 | |
| 4,219,888 | Institution | 2.55% | 320,795,886 | |
| 3,982,987 | Institution | 2.41% | 302,786,672 | |
| 3,803,181 | Institution | 2.30% | 289,117,820 | |
| 2,867,226 | Institution | 1.73% | 217,966,521 | |
| 2,165,314 | Institution | 1.31% | 164,607,170 | |
| 1,655,237 | Institution | 1.00% | 125,831,117 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,996,832 | Institution | 3.02% | 375,212,115 | |
| 3,622,856 | Institution | 2.19% | 272,040,257 | |
| 2,026,226 | Institution | 1.23% | 152,149,310 | |
| 1,810,569 | Institution | 1.10% | 135,955,626 | |
| 1,210,926 | Institution | 0.73% | 93,059,663 | |
| 1,189,672 | Institution | 0.72% | 90,438,865 | |
| 1,126,884 | Institution | 0.68% | 86,601,035 | |
| 972,323 | Institution | 0.59% | 73,915,994 | |
| 788,219 | Institution | 0.48% | 60,574,630 | |
| 617,713 | Institution | 0.37% | 46,958,542 |
FAQ
Who Owns Ionis Pharmaceuticals (IONS)?
According to the latest TipRanks data, approximately 4.51% of the company's stock is held by institutional investors, 0.74% is held by insiders, and 37.52% is held by retail investors.
What percentage of Ionis Pharmaceuticals (IONS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.51% of Ionis Pharmaceuticals (IONS) stock is held by institutional investors.
What percentage of Ionis Pharmaceuticals (IONS) stock is held by retail investors?
According to the latest TipRanks data, approximately 37.52% of Ionis Pharmaceuticals (IONS) stock is held by retail investors.
Who owns the most shares of Ionis Pharmaceuticals (IONS)?
Vanguard owns the most shares of Ionis Pharmaceuticals (IONS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.